Vertex Pharmaceuticals Q3 Adjusted Earnings Fall, Revenue Rises
MT newswire2026/11/02 20:08Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
04:08 PM EST, 11/02/2026 (MT Newswires) -- Vertex Pharmaceuticals (VRTX) reported Q3 adjusted earnings late Monday of $4.76 per diluted share, compared with $4.80 a year earlier. Analysts polled by FactSet expected $4.82. Revenue for the quarter ended Sept. 30 was $3.44 billion, compared with $3.08 billion a year earlier. Analysts expected $3.42 billion. For the full-year, the company said it now expects revenue of $13.15 billion to $13.25 billion, compared with its previous guidance of $13.1 billion to $13.2 billion Analysts expect $13.26 billion.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!
You may also like
Crypto prices
MoreBitcoin
BTC
$60,591.37
-4.38%
Ethereum
ETH
$1,701.6
-5.15%
Tether USDt
USDT
$0.9992
+0.01%
BNB
BNB
$568.65
-3.67%
USDC
USDC
$1
+0.01%
XRP
XRP
$0.9262
-6.04%
Solana
SOL
$69.64
-6.99%
TRON
TRX
$0.3050
-1.84%
Hyperliquid
HYPE
$62.23
-9.48%
Zcash
ZEC
$799.82
-14.68%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now